Replies to post #44100 on Propanc Biopharma Inc (PPCB)

[zino]

Patent Value by Investment Bank >>> $26,OOO,OOO Dollars

Valuation undertaken by a North American investment bank, Valued Propanc’s intellectual property (IP) assets at $26 million, based on the Company’s initial target patient populations, including pancreatic, ovarian, prostate and colorectal cancers
https://ir.propanc.com/press-releases/detail/131/propanc-biopharmas-ceo-believes-lead-asset-could-unlock

PPCB 65 Patents....
either in force, or currently under examination in global jurisdictions
https://www.propanc.com/news-media/press-releases/detail/135/propanc-biopharma-receives-notice-of-allowance-for

[marylandstockguy]

Yup agreed. I'm just looking at the current market cap. As of now, it's just over $1.1 million. Peanuts for what is in the pipeline, pre-clinical or not. I'm not listening to the "well this could happen or that could happen, or there could be an RS", blah blah blah crowd. Sure...but as of now, the market cap is $1.1 million. That's what I'm looking at - I'm not trying to speculate on RS or massive dilution, etc. We don't know. There could be dilution into the OS at some point, but it might not be until this gets to a penny - nobody knows. At a penny, this would be about a $19 million market cap with current OS - not crazy at all.

Bottom line - why not buy at $1.1 mil market cap, and if it has a nice run sell half and hold free shares?

[QUEEN2]

Almost 40 patents.....LOOOL!!!
If the company really had all these patents, validated, the pps would surely not be at this price